当前位置: 首页 > 期刊 > 《中外医疗》 > 201435
编号:13655541
血清TK1和CA15—3含量在乳腺癌患者中的变化及临床价值(2)
http://www.100md.com 2014年12月15日 《中外医疗》 201435
     [参考文献]

    [1] Jemal A, Bray F Center MM , et al. Global cancer statistics[J].CA Cancer J Clin ,2011, 61(2): 69-90.

    [2] 张国庆, 焦顺昌, 魏秀芳. 血清胸苷激酶1 在中老年人肿瘤免疫监测中的作用[J]. 现在肿瘤医学, 2008, 16(5):831-832.

    [3] 崔红霞, 韩存芝, 杜丽莉等. 肿瘤标志物在监测乳腺癌患者复发转移中的意义[J]. 中国循证医学杂志, 2008, 8(10):842-845.

    [4] Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breastcancer[J]. J Clin Oncol .2007, 25(33):5287-5312.

    [5] He Q, Fornander T, Johansson H, et al. Thymidine kinase 1 in serum predicts increased risk of distant or loco-regional recurrence following surgery in patients with early breast cancer[J]. Anticancer Res. 2006, 26(6C): 4753-4759.

    [6] HOLDENRIEDER S, VON P J, DUELL T, et al. Clinical relevance of thymidine kinase for the diagnosis, therapy monitoring and prognosis of non-operable lung cancer[J]. Anticancer Res, 2010, 30(5): 1855-1862.

    [7] XU Y, SHI Q L, MA H, et al. High thymidine kinase 1 (TK1)expression is a predictor of poor survival in patients with pT1of lung adenocarcinoma[J]. Tumor Biol, 2012, 33(2): 475-483.

    [8] NISMAN B, YUTKIN V, NECHUSHTAN H, et al. Circulating tumor M2 pyruvate kinase and thymidine kinase 1 are potential predictors for disease recurrence in renal cell carcinoma after nephrectomy[J]. Urology, 2010, 76(2): 1-6.

    [9] PROCHAZKA V, FABER E, RAIDA L, et al. High baseline serum thymidine kinase 1 level predicts unfavorable outcome in patients with follicular lymphoma[J]. Leuk Lymphoma,2012, 53(7): 1306-1310.

    [10] WU B J, LI W P, QIAN C, et al. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma[J]. Tumor Biol, 2013, 34(2): 643-648.

    [11] 杨雅洁,温文,关弘,等.乳腺癌中胸苷激酶1的表达及其临床意义[J].临床与实验病理学杂志,2012,28(5):562-564.

    [12] 陈曲波,黎翠翠,赵蓉,等.血清胸苷激酶1在乳腺癌诊治中的应用[J].实用医学杂志,2012,28(5):728-730.

    [13] 伍启康,雷兰芳,黄燕婷,等.血清胸苷激酶l水平的变化在乳腺癌诊断和治疗的应用价值研究[J].国际医药卫生导报,20ll,l7(20):2546-2548.

    [14] 陶晓军,陈桂明,冯晓鸿,等.血清tk1、TPS、Ca15-3联合检测在乳腺癌诊断中的临床价值[J].国际检验医学杂志,2012,33(16):1943-1946.

    (收稿日期:2014-09-15), 百拇医药(段春霞 郝艳梅 陈丽霞)
上一页1 2